Oxyntomodulin vs Lixisenatide

Head-to-head comparison of Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) and Lixisenatide (Exendin-4-derived GLP-1 receptor agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyOxyntomodulinLixisenatide
CategoryWeight ManagementWeight Management
Full NameEndogenous glucagon-like peptide 1 and glucagon co-agonist peptideExendin-4-derived GLP-1 receptor agonist
Molecular Weight~4,200 Da4858 Da
Half-Life12-15 minutes2-4 hours
Amino Acids3744
Typical DoseResearch doses vary; commonly 100-300 mcg in small human studies10-20 mcg daily
RouteSubcutaneous/IVSubcutaneous
Purity≥98%≥98%
Studies Count80400
Research StatusClinicalApproved

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

Lixisenatide Benefits

  • postprandial glucose control
  • modest weight loss
  • appetite reduction
  • short-acting option

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

Lixisenatide Dosing

10 mcg SC daily for 14 days|Increase to 20 mcg daily|Inject before the first meal of the day

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Lixisenatide Side Effects

  • nausea
  • vomiting
  • hypoglycemia when combined with insulin

Research Overview

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Lixisenatide

Lixisenatide produces small but measurable weight loss in diabetes trials while improving postprandial glucose excursions. Its shorter half-life makes it a useful reference compound for first-generation incretin mimetics.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Oxyntomodulin stacks with:

calorie-deficitresistance-training

Lixisenatide stacks with:

basal-insulinmeal-plan
GLP-1glucagon-coagonistendogenous-peptideappetite-regulationGLP-1RAshort-actingpostprandial-controlweight-loss-adjacent